- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Smyrna Today
By the People, for the People
UCB's Smyrna Headquarters Ties Into Georgia's New Biotech Mega-Campus
The $2 billion UCB manufacturing facility in Gwinnett builds on the company's existing North American headquarters in Smyrna.
Apr. 11, 2026 at 5:37am
Got story updates? Submit your updates here. ›
The Rowen campus project aims to create a vibrant biotech hub that will connect Smyrna's existing life sciences presence to a broader regional ecosystem.Smyrna TodayA major $2 billion UCB manufacturing facility in Gwinnett, Georgia is building on the company's existing North American headquarters in Smyrna, where about 400 people already work. The new Rowen campus project aims to create a Georgia version of Research Triangle Park, tying Smyrna's life-sciences presence into a broader regional hub for high-paying biotech jobs and investment.
Why it matters
The expansion of UCB's operations in the Smyrna and Gwinnett areas is part of a broader effort by Georgia to establish a biotech and life sciences hub similar to North Carolina's Research Triangle Park. By anchoring this new mega-campus with an existing facility in Smyrna, the state is hoping to leverage the city's existing talent and infrastructure to attract more biotech companies and high-paying jobs to the region.
The details
UCB, a global biopharmaceutical company, currently has its North American headquarters located in Smyrna, Georgia, where about 400 people are employed. The company is now investing $2 billion to build a new manufacturing facility as part of the Rowen project, a 2,000-acre mega-campus in Gwinnett County that is being developed to attract more biotech and life sciences companies to the region. The Rowen project is modeled after North Carolina's successful Research Triangle Park, aiming to create a similar cluster of high-tech companies, research institutions, and talent in the metro Atlanta area.
- UCB opened its North American headquarters in Smyrna in the early 2000s.
- The $2 billion UCB manufacturing facility in Gwinnett is currently under construction and is expected to be completed by 2028.
The players
UCB
A global biopharmaceutical company that has its North American headquarters located in Smyrna, Georgia, where about 400 people are employed. UCB is investing $2 billion to build a new manufacturing facility as part of the Rowen project in Gwinnett County.
Rowen Project
A 2,000-acre mega-campus development in Gwinnett County, Georgia that is being modeled after North Carolina's successful Research Triangle Park. The goal is to attract more biotech and life sciences companies to the metro Atlanta region.
What’s next
The $2 billion UCB manufacturing facility in Gwinnett is expected to be completed by 2028, further expanding the company's presence in the metro Atlanta region and contributing to the broader goal of establishing Georgia as a biotech and life sciences hub.
The takeaway
The expansion of UCB's operations in Smyrna and Gwinnett is a significant step in Georgia's efforts to create a biotech and life sciences cluster modeled after North Carolina's successful Research Triangle Park. By leveraging an existing corporate presence and talent pool in Smyrna, the state is aiming to attract more high-paying jobs and investment in the growing field of biopharmaceuticals and life sciences.
